June 6, 2013 Peter G. Ruminski MS Executive Director.

The Center for World Health & Medicine at Saint Louis University One Grand Boulevard DuBourg Hall, Suite 306 St. Louis, MO 63103 Dear Mr. Ruminski: I'd appreciate you reviewing the following information and providing me with an answer to a quick question for an item I'm reporting on my blog, The Sidebar. From SLU Scientists Partner on Malaria Research, a February 18, 2011 press release issued by SLU media representative Nancy Solomon: The Center for World Health & Medicine at Saint Louis University and China's Guangzhou Institutes of Biomedicine and Health (GIBH) are forming a global research partnership that initially will focus on new treatments for malaria. According to the online biography of Dr. Xiaoping Chen, Principal Investigator, Director of Center for Infection and Immunity at GIBH: Currently, we are further developing antimalarial drugs based on a new target, plasmepsin V in collaboration with the scientists at Saint Louis University and Washington University, see the link: Inhibitors of Plasmepsin V as Novel AntiMalarial Agents. From the linked page in the preceding paragraph: GIBH in partnership with the Center for World Health & Medicine (CWHM) at Saint Louis University has established a powerful collaboration. From GIBH's External Collaborations web page: (Currently, GIBH has an external partnership with) The Center for World Health & Medicine at Saint Louis University to develop anti-malaria therapies...Project Leaders at GIBH are Xiaoping Chen.... From Scientists linked to Heimlich investigated Experiment infects AIDS patients in China with malaria by Robert Anglen, Cincinnati Enquirer, February 16, 2003: (Dr.) Heimlich's experiments - which seek to destroy HIV, the AIDS-causing virus, by inducing high malarial fevers- have been criticized by the Centers for Disease Control and the Food and Drug Administration and condemned by other health professionals and human rights advocates as a medical "atrocity.'' ...(Documents) obtained by the Enquirer show (UCLA) doctors have been active in the malaria experiments since 1996. ..."I greatly appreciated all of the data you shared with us on this visit," Dr. (John) Fahey wrote to Chen Xiao Ping, the doctor overseeing the experiments for Dr. Heimlich in China.

From UCLA Medical Institutional Review Board Issues Its Determination in the Fahey Case Regarding Claims About Malariotherapy Studies for HIV by Max Benavidez , an April 16, 2003 UCLA news release: The MIRB determined that Fahey, while not personally involved in the clinical trials, was involved in evaluating data and biological samples brought to UCLA from China by Dr. Xiao Peng [sic] Chen under the Fogarty International Program. Since Chen's work was performed as part of the Fogarty Program at UCLA and was under Fahey's supervision, the MIRB determined that Fahey was engaged in human subjects research. Would you also please also read my May 13, 2013 letter to Jerry A. Menikoff, MD JD, Director of the U.S. Department of Health and Human Services's Office for Human Research Protections, posted on my blog? You may click here to download the letter. Here's my question. (I may have follow-ups.) Is the Dr. Xiaoping Chen with whom your department is partnering the same doctor who was involved in my father's malariotherapy experiments? Thanks for your consideration and I look forward to your reply. Please feel free to communicate with me by via e-mail. Sincerely,

Peter M. Heimlich 3630 River Hollow Run Duluth, GA 30096 ph: (208)474-7283 e-mail: peter.heimlich@gmail.com website: MedFraud.info blog: The Sidebar cc: Nancy Solomon